Search results for GLP-1

Dr. Derya Unutmaz explains longevity escape velocity and how AI, cancer treatments, GLP-1 drugs, and regenerative medicine may extend healthy life.

“Doctors have long wondered whether the heart benefits of the GLP-1 receptor agonist semaglutide (Ozempic®/Wegovy®) come only from helping people lose weight, or if the drug directly protects the cardiovascular system.”

“The divergence suggests that the composition of rapid weight loss may depend on whether muscle can preserve the flexibility to switch toward alternative fuels when energy intake falls. In Aliquot #128, I examine how GLP-1 drugs promote weight loss, the trade-offs they may carry, and strategies that may help support long-term health.”

“Dr. Patrick then discusses reward signaling. In a small human imaging study, higher habitual added-sugar intake was associated with greater dorsal-striatal responses to food cues after a glucose drink and a smaller GLP-1 response.”

“Randomized controlled trial finds that type 2 diabetics given a diet high in fiber improved the secretion of hormones involved in insulin production (GLP-1) and lowered blood glucose levels (HbA1c) via changes in the gut microbiome.”

“Pharmaceutical treatments for type 2 diabetes include GLP-1 activators, which can be effective at reducing blood sugar levels and increasing feelings of satiety after eating. High protein diets (30 percent of calories) have also been shown to enhance incretin signaling, making them an important strategy for treating prediabetes.”

“Only the inulin groups showed increases in the short-chain fatty acid (SCFA) butyrate and in the peptide hormone glucagon-like peptide-1 (GLP-1). Higher GLP-1 levels were linked to stronger grip strength, suggesting a possible connection between the gut and muscle function.”

“From the article: > LP-1 is released from the wall of the gut after eating and acts to stimulate insulin from the pancreas to control blood sugar levels. This was known but what has now been unearthed is that GLP-1 also stimulates a small sensory organ called the carotid body located in the neck. View full publication.”

“A researcher used a validated mathematical model to simulate the body's weight-loss response to calorie restriction, glucagon-like peptide receptor agonists (GLP-1 RAs, a class of drugs primarily used to treat type 2 diabetes and obesity), and bariatric (gastric bypass) surgery.”